Pre-order Enquiry
Request Free Sample
Global Implantable Infusion Pumps Market Insights, Forecast to 2028
SKU ID : QYR-20398705 | Publishing Date : 04-Mar-2022
Request Sample
Request Customization
Check Discounts
Market Analysis and Insights: Global Implantable Infusion Pumps Market
Due to the COVID-19 pandemic, the global Implantable Infusion Pumps market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Piston Type Infusion Pumps accounting for % of the Implantable Infusion Pumps global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Implantable Infusion Pumps market size is valued at US$ million in 2021, while the US and Europe Implantable Infusion Pumps are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Implantable Infusion Pumps landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Implantable Infusion Pumps include Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies and Avery Biomedical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Implantable Infusion Pumps Scope and Segment
Implantable Infusion Pumps market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Implantable Infusion Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Piston Type Infusion Pumps
Creeping Type Infusion Pumps
Segment by Application
Hospitals
Clinics
Others
By Company
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Due to the COVID-19 pandemic, the global Implantable Infusion Pumps market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Piston Type Infusion Pumps accounting for % of the Implantable Infusion Pumps global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Implantable Infusion Pumps market size is valued at US$ million in 2021, while the US and Europe Implantable Infusion Pumps are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Implantable Infusion Pumps landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Implantable Infusion Pumps include Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies and Avery Biomedical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Implantable Infusion Pumps Scope and Segment
Implantable Infusion Pumps market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Implantable Infusion Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Piston Type Infusion Pumps
Creeping Type Infusion Pumps
Segment by Application
Hospitals
Clinics
Others
By Company
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
